Sodium phosphate monobasic monohydrate

CAS : 10049-21-5

Ref. 3D-FN30561

Informations sur le produit

• Nom: Sodium phosphate monobasic monohydrate
• Synonymes: Sodium dihydrogen phosphate monohydrateMonosodium phosphate monohydrate, BOD phosphate buffer SOLUTION A, Buffer, Phosphate, Monobasic sodium phosphate monohydrate, Monosodium phosphate monohydrate, Phosphoric Acid, Monosodium Salt, Monohydrate, Sodium Dihydrogen Phosphate Hydrate (1:1:1), Sodium Dihydrogen Phosphate Monohydrate, Sodium Phosphate Hydrate, Sodium dihydrogen phosphate hydrate, Sodium phosphate, monobasic, buffer COLOUR CODED CONCENTRATED SOLUTION PH 7 (PHOSPHATE) YELLOW, buffer COLOUR CODED SOLUTION PH 7 (PHOSPHATE) YELLOW, buffer CONCENTRATE, PH 7 (PHOSPHATE), buffer FOR BOD, buffer MDB 9.50, buffer PH 7.0 (PHOSPHATE)
• CAS: 10049-21-5

Description

Sodium phosphate monobasic monohydrate is a nonsteroidal anti-inflammatory drug that belongs to the class of sodium salts. It is used to treat bowel disease and has been shown to reduce the production of prostaglandins in the stomach, which are mediators of inflammation. Sodium phosphate monobasic monohydrate can also be used for its anti-inflammatory effects on other parts of the body, such as joints or muscles. This drug is often used for rheumatoid arthritis, osteoarthritis, or ankylosing spondylitis. The molecular weight of this compound is 288.3 g/mol and it has a melting point of 519°C. Sodium phosphate monobasic monohydrate can be administered orally or intravenously and should not be given with food or antacids due to its high solubility in water. Sodium phosphate monobasic monohydrate also has potential cytotoxicity and significant cytotoxicity against human cells in vitro

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 137.99 g/mol
• Formule: H₂NaO₄P·H₂O
• Degré de pureté: Min. 98 Area-%
• Couleur/Forme: Powder